Why TRT Raised Your Blood Pressure (and How to Fix It)

Your blood pressure goes up on TRT and the default assumption is that testosterone itself is the problem. That assumption is wrong, and it leads men to either stop therapy unnecessarily or spend years managing a symptom without ever addressing the cause.

There are three separate mechanisms driving blood pressure up on TRT, and each one operates through a completely different pathway. Understanding all three is what lets you actually fix it.

Start with the full picture. Testosterone does several things at once when you introduce it into the body. It increases red blood cell production. It gets converted into estrogen through a process called aromatization. And it expands your total blood volume. All three of those changes affect your cardiovascular system, and if any one of them runs unchecked, your blood pressure climbs. The goal is not to avoid those changes. The goal is to manage them.

The first and most significant mechanism is something called erythrocytosis, which is when your body produces more red blood cells than your vascular system can efficiently move. Testosterone signals the kidneys to produce more of a hormone called erythropoietin, and erythropoietin tells your bone marrow to manufacture more red blood cells. The relationship is dose-dependent, meaning the more testosterone you take, the more red blood cells your body makes. Research confirmed this in a study where hemoglobin and hematocrit rose in a direct linear relationship with testosterone dose across both young and older men.

The problem with too many red blood cells is a mechanical one. Your blood becomes thicker, and thicker blood requires more force to move through your vessels, which means your heart has to push harder, and that increased force registers as higher blood pressure. Think of it like trying to push honey through a garden hose instead of water. The hose has not changed. The pump has not changed. But the pressure required to move anything through it is dramatically higher.

A randomized controlled trial measured exactly how much this matters. Men whose hematocrit rose more than 6 percentage points on testosterone therapy saw their systolic blood pressure increase by 13.2 mmHg compared to the placebo group. That is not a marginal number. A 13-point rise in systolic pressure is the kind of change that moves someone from a normal range into a hypertensive category.

The clinical threshold most providers use is a hematocrit of 54%, and the evidence supports treating that as a hard ceiling. Above that level the blood viscosity risk becomes significant enough that dose reduction or discontinuation is the standard recommendation. Getting your hematocrit checked every six months is not overcautious. It is the basic monitoring that keeps this from becoming a problem in the first place.

The second mechanism is estradiol, and this is where a lot of well-intentioned clinical management actually makes things worse. When testosterone enters your body, some of it gets converted into estrogen through a process involving an enzyme called aromatase. Elevated estradiol causes your body to retain water through effects on the renal tubules, which are the filtering structures inside your kidneys that regulate what stays in your body and what gets excreted. More water retained means more volume in your bloodstream, and more volume means higher pressure.

The obvious response to that sounds like it should be blocking the aromatase enzyme with something called an aromatase inhibitor, which reduces how much testosterone converts to estrogen. And that does reduce water retention. But it also removes something your cardiovascular system depends on. Estradiol is not just a byproduct of testosterone metabolism. It is directly protective for your blood vessels. Research in animal models showed that blocking aromatase increased mean arterial pressure, which is the opposite of what you are trying to achieve.

So overcorrecting estradiol does not fix the blood pressure problem. It trades one version of it for another. The target range that balances water retention against cardiovascular protection sits around 20 to 40 pg/mL on a sensitive estradiol assay, and the most reliable way to stay in that range is by adjusting how frequently you inject, not by adding an aromatase inhibitor to your protocol. More frequent, smaller injections produce steadier testosterone levels, which means steadier aromatization, which means less estradiol swinging out of range in either direction.

The third mechanism has nothing to do with your labs at all. Testosterone increases your total blood volume, and your cardiovascular system has to be capable of handling that expanded volume. The heart and blood vessels adapt to higher volume through a process that requires cardiovascular stress to trigger, meaning your body needs regular aerobic exercise to develop the capacity to manage more blood efficiently. Without that adaptation, you are running a higher-volume system through infrastructure that was built for a lower-volume load, and pressure builds up.

This is not a metaphor. Cardiovascular training physically remodels the heart and expands the elasticity of your vessels. Men on TRT who are not doing regular cardio are missing the adaptation that makes the hormonal environment manageable. The fix here is not pharmaceutical. It is aerobic exercise done consistently.

Now here is what changes when all three of those things are actually managed. A study following 737 men on long-term testosterone therapy found that the men not taking blood pressure medication saw their systolic blood pressure drop by about 12.5 points. In the same study, 33 out of 202 men who had been on antihypertensive medication were able to discontinue it entirely over the course of the study period. That is not the outcome you would expect if testosterone were inherently bad for blood pressure.

The men for whom TRT becomes a cardiovascular problem are the men whose hematocrit goes unmonitored, whose estradiol gets crushed by an aromatase inhibitor or ignored entirely, and who are not developing the cardiovascular capacity to handle the changes TRT produces.

Testosterone does not raise your blood pressure. An unmanaged hormonal environment raises your blood pressure. The therapy is not the variable. The monitoring is.

---

References

1. Olesen TB, Glintborg D, Johnk F, et al. 2024. Blood pressure responses to testosterone therapy are amplified by hematocrit levels in opioid-induced androgen deficiency. Journal of Hypertension, 423, 531-540. Finding: Office SBP increased 6.2 mmHg in testosterone group vs 7.0 mmHg decrease in placebo net 13.2 mmHg. Men with hematocrit rise >6% saw clinically relevant BP increases. Source
2. Coviello AD, Kaplan B, Lakshman KM, et al. 2008. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. Journal of Clinical Endocrinology and Metabolism, 933, 914-919. Finding: Hemoglobin and hematocrit increased in a linear, dose-dependent fashion. Source
3. Almutlaq RN, Newell-Fugate AE, Evans LC, et al. 2022. Aromatase inhibition increases blood pressure and markers of renal injury in female rats. American Journal of Physiology Renal Physiology, 3232, F170-F181. Finding: Blocking aromatase increased mean arterial pressure. Source
4. Hackett G, Mann A, Haider A, et al. 2024. Testosterone replacement therapy: effects on blood pressure in hypogonadal men. World Journal of Mens Health, 422, 431-443. Finding: Long-term TRT associated with significant SBP and DBP reductions. 33 of 202 men on antihypertensives discontinued them. Source
5. Agrawal P, Singh SM, Kohn T. 2023. Management of erythrocytosis in men receiving testosterone therapy. European Urology Focus, 91, 139-142. Finding: Hematocrit >54% requires dose decrease or discontinuation. Source
6. Johannsson G, Gibney J, Wolthers T, et al. 2005. Independent and combined effects of testosterone and growth hormone on extracellular water in hypopituitary men. Journal of Clinical Endocrinology and Metabolism, 907, 3891-3896. Finding: Testosterone independently increased extracellular water through renal tubule effects. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness